Literature DB >> 16306356

Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells.

Katharina Laubner1, Timothy J Kieffer, Ni T Lam, Xinjie Niu, Franz Jakob, Jochen Seufert.   

Abstract

Leptin inhibits insulin secretion and preproinsulin gene expression in pancreatic beta-cells, but signal transduction pathways and molecular mechanisms underlying this effect are poorly characterized. In this study, we analyzed leptin-mediated signal transduction and preproinsulin gene regulation at the molecular level in pancreatic beta-cells. Leptin stimulation led to janus kinase (JAK)2-dependent phosphorylation and nuclear translocation of the transcription factors signal transducer and activator of transcription (STAT)3 and STAT5b in INS-1 beta-cells. Leptin also induced mRNA expression of the JAK-STAT inhibitor suppressor of cytokine signaling (SOCS)3 in INS-1 beta-cells and human pancreatic islets in vitro and in pancreatic islets of ob/ob mice in vivo. Transcriptional activation of the rat SOCS3 promoter by leptin was observed with concomitant leptin-induced STAT3 and STAT5b DNA binding to specific promoter regions. Unexpectedly, SOCS3 inhibited both basal and STAT3/5b-dependent rat preproinsulin 1 gene promoter activity in INS-1 cells. These results suggest that SOCS3 represents a transcriptional inhibitor of preproinsulin gene expression, which is induced by leptin through JAK-STAT3/5b signaling in pancreatic beta-cells. In conclusion, although SOCS3 is believed to be a negative feedback regulator of JAK-STAT signaling, our findings suggest involvement of SOCS3 in a direct gene regulatory pathway downstream of leptin-activated JAK-STAT signaling in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306356     DOI: 10.2337/diabetes.54.12.3410

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  39 in total

Review 1.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

2.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 3.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

4.  Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells.

Authors:  Ramkumar Mohan; Yiping Mao; Shungang Zhang; Yu-Wei Zhang; Cheng-Ran Xu; Gérard Gradwohl; Xiaoqing Tang
Journal:  J Biol Chem       Date:  2015-06-24       Impact factor: 5.157

Review 5.  Minireview: CNS Mechanisms of Leptin Action.

Authors:  Jonathan N Flak; Martin G Myers
Journal:  Mol Endocrinol       Date:  2015-10-20

6.  Leptin downregulates expression of the gene encoding glucagon in alphaTC1-9 cells and mouse islets.

Authors:  L Marroquí; E Vieira; A Gonzalez; A Nadal; I Quesada
Journal:  Diabetologia       Date:  2011-01-14       Impact factor: 10.122

Review 7.  A role for leptin-regulated neurocircuitry in subordination stress.

Authors:  Jonathan N Flak
Journal:  Physiol Behav       Date:  2016-11-22

8.  A priori-defined diet quality indices, biomarkers and risk for type 2 diabetes in five ethnic groups: the Multiethnic Cohort.

Authors:  Simone Jacobs; Carol J Boushey; Adrian A Franke; Yurii B Shvetsov; Kristine R Monroe; Christopher A Haiman; Laurence N Kolonel; Loic Le Marchand; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2017-08       Impact factor: 3.718

9.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 10.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.